A
Atea Pharmaceuticals (AVIR)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Atea Pharmaceuticals (AVIR)
Atea Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections.... Read more
- USD2.92
- USD3.04
- USD2.92
- USD4.15
- --
- 427.78k
- 251M
- 2.46
- -16.40%
Stock News
2 hours ago
Companies like GameStop and Trump Media are buying bitcoin. Here’s how investors should proceed.
MarketWatch
2 hours ago
Why Jim Cramer is frustrated by Friday's lower market — plus, good news for 2 of our bank stocks
CNBC
3 hours ago
Unity upgrade, UiPath earnings, Regeneron drug trial results
Yahoo
5 hours ago
Having a master's degree doesn't make you a better worker, say hiring managers—but you’ll still get paid more
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
